Elevidys package insert

Package Insert - ELEVIDYS. Gabapentinoids. Gralise (gabapentin) Horizant (gabapentin enacarbil) Lyrica (pregabalin) Lyrica CR (pregabalin) Neurontin (gabapentin) Withdrawal syndrome.

Elevidys was approved under accelerated approval based on expression of Elevidys microdystrophin in Elevidys [package insert]. Cambridge, MA;

New policy for Elevidys created. References: 1. Elevidys [package insert]. Cambridge, MA; Sarepta Therapeutics, Inc. 2024. 2. Birnkrant DJ

- Elevidys [package insert]. Cambridge, MA; Sarepta Therapeutics, Inc.; June 2024. Accessed June 2024. - Topaloglu H, Gloss D, Moxley RT 3rd

PACKAGE INSERT INFORMATION: INDICATION, AGE, DOSE, AND ANY. PRE Elevidys (delandistrogen moxeparvovec-rokl) [prescribing information].

package insert for recommended corticosteroid dosing during therapy); Elevidys dose (in mL) = patient body weight (in kilogram) x 10.

ELEVIDYS (delandistrogene moxeparvovec -rokl) Prior Auth Criteria Proprietary Information. Restricted Access Do not disseminate or copy without approval. 2024, Magellan Rx Management and post- infusion (refer to the package insert for recommended corticosteroid dosing during therapy); AND

ELEVIDYS is a gene therapy for Duchenne muscular dystrophy (DMD) in ambulatory pediatric patients aged 4 through 5 years. Find the package insert, approval letter, summary basis, and other supporting documents on the FDA website.

Amondys 45, Exondys 51. Vyondys 53, Viltepso) after Elevidys PACKAGE INSERT INFORMATION: INDICATION, AGE, DOSE, AND ANY. PRE